Cost-effectiveness of TTVR with EVOQUE system in patients with Severe Tricuspid Regurgitation based on TRISCEND II trial

ESC Heart Failure · Published 2026-05-12 · DOI 10.1093/eschf/xvag137

Free full text

Authors (7)

Apolline Grangeon, Martin Connock, Peter Auguste, Jean François Obadia, Maurice Enriquez-Sarano, Benjamin Essayagh, Xavier Armoiry

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Grangeon, A., Connock, M., Auguste, P., et al. (2026). Cost-effectiveness of TTVR with EVOQUE system in patients with Severe Tricuspid Regurgitation based on TRISCEND II trial. ESC Heart Failure. https://doi.org/10.1093/eschf/xvag137

Related articles